Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog)

Brain Research

Volumn 1514, Issue , 2013, Pages 12-17

  Wharton, Whitney ^a   Gleason, Carey E ^a,b   Miller, Virginia M ^c   Asthana, Sanjay ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Clinical trial; Cognition; Estrogen; Hormone therapy; KEEPS; Menopause

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTRONE SULFATE; FOLLITROPIN; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; SEX HORMONE BINDING GLOBULIN;

ANGINA PECTORIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CANCER RISK; CARDIOVASCULAR RISK; CLIMACTERIUM; COGNITION; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY CALCIFICATION; DISEASE COURSE; ENDOMETRIUM CANCER; FOLLITROPIN BLOOD LEVEL; HEART INFARCTION; HORMONAL THERAPY; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOEMBOLISM; UNITED STATES; WOMEN'S HEALTH;

ADULT; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; COGNITION DISORDERS; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MOOD DISORDERS; POSTMENOPAUSE; VASCULAR CALCIFICATION; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 84878500301     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.04.011     Document Type: Article

References (32)

1. B.R. Bhavnani Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's J. Steroid Biochem. Mol. Biol. 85 2-5 2003 473 482
2. M.J. Budoff Effects of hormone replacement on progression of coronary calcium as measured by electron beam tomography J. Women's Health 14 5 2005 410 417
3. B. de Lignieres Oral micronized progesterone Clin. Ther. 21 1 1999 41 60; discussion 1-2
4. M.A. Espeland Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study JAMA 291 24 2004 2959 2968
5. E.W. Freeman A placebo-controlled study of effects of oral progesterone on performance and mood Br. J. Clin. Pharmacol. 33 3 1992 293 298
6. C.E. Gleason Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation Neurology 67 11 2006 2039 2041
7. M.P. Guay Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication Pharmacoepidemiol Drug Saf. 16 1 2007 17 27
8. S.M. Harman KEEPS: the Kronos Early Estrogen Prevention Study Climacteric 8 1 2005 3 12
9. Henderson, V.W.; et al.; Prior use of hormone therapy and incident Alzheimer s disease. In: The Women s Health Initiative Memory Study, in American Academy of Neurology Annual Meeting. 2007, Boston, MA.
10. H.N. Hodis Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 135 11 2001 939 953
11. E. Hogervorst Hormone replacement therapy to maintain cognitive function in women with dementia Cochrane. Database Syst. Rev. 1 2009 CD003799
12. J. Hsia Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative Arch. Intern. Med. 166 3 2006 357 365
13. R. Krug A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women Psychoneuroendocrinology 31 8 2006 965 975
14. K.L. Lokken The relationship between menopausal status, phase of menstrual cycle, and replacement estrogen on cognition in healthy women without dementia J. Psychol. 140 6 2006 533 547
15. J.E. Manson Estrogen plus progestin and the risk of coronary heart disease N. Engl. J. Med. 349 6 2003 523 534
16. J.E. Manson Postmenopausal hormone therapy: new questions and the case for new clinical trials Menopause 13 1 2006 139 147
17. V.M. Miller Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS) J. Cardiovasc. Transl. Res. 2 3 2009 228 239
18. J. Nilsen Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate Endocrinology 143 1 2002 205 212
19. A. Paganini-Hill Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women Am. J. Obstet. Gynecol. 174 3 1996 897 902
20. P. Raggi Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction Am. J. Cardiol. 92 7 2003 827 829
21. S.R. Rapp Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 20 2003 2663 2672
22. M.M. Rice Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the Kame Project Arch. Intern. Med. 160 11 2000 1641 1649
23. L.L. Schierbeck Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial BMJ 345 2012 e6409
24. A.E. Schindler Climacteric symptoms and hormones Gynecol. Endocrinol. 22 3 2006 151 154
25. H. Shao Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study Neurology 79 18 2012 1846 1852
26. S.A. Shumaker Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 20 2003 2651 2662
27. S.A. Shumaker Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study JAMA 291 24 2004 2947 2958
28. R. Sitruk-Ware Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications - a review Contraception 36 4 1987 373 402
29. A.H. Soderpalm Administration of progesterone produces mild sedative-like effects in men and women Psychoneuroendocrinology 29 3 2004 339 354
30. W. Wharton Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias Maturitas 64 3 2009 182 187
31. J.E. Yonker Verified hormone therapy improves episodic memory performance in healthy postmenopausal women Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn. 13 3-4 2006 291 307
32. P.P. Zandi Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study JAMA 288 17 2002 2123 2129